StonvexLoading…
StonvexStonvexStonvexCore line items from PDD's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $61.75B | $53.96B | $34.88B | $18.93B |
Operating Income | $13.31B | $14.85B | $8.27B | $4.41B |
Net Income | $13.99B | $15.40B | $8.45B | $4.57B |
EPS (Diluted) | $2.36 | $2.60 | $1.45 | $0.79 |
Total Assets | $90.10B | $69.19B | $49.03B | $34.38B |
Total Liabilities | $30.98B | $26.27B | $22.65B | $17.30B |
Cash & Equivalents | $15.57B | $7.91B | $8.42B | $4.98B |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 5.69B | 5.57B | 5.50B | 5.28B |